Funded Startups in Lund
Across the 39 most recent Lund entries with disclosed amounts, AlixLabs’ $16M Series A on 2025-11-18 is the largest disclosed round, far above the next-lar…
Across the 39 most recent Lund entries with disclosed amounts, AlixLabs’ $16M Series A on 2025-11-18 is the largest disclosed round, far above the next-largest disclosed amounts of $13M (Enzymatica, 2024-09-12) and $8M (Zerotude, 2024-11-04). Most other disclosed rounds cluster well below that top tier, with several between ~$2M and $4M (e.g., Saveggy $2M on 2024-04-15; Cantargia $3M on 2025-06-17; Cellevate $4M on 2023-10-10).
The list also shows a repeated stage/label pattern: 20 of 39 rows are marked “Series Unknown,” and 3 rows are explicitly “undisclosed” by amount. Temporally, multiple biotech-leaning deals appear in mid-2025 (SynAct Pharma $2M on 2025-07-15; Qlucore $580K on 2025-06-24; Cantargia $3M on 2025-06-17; TerraNet $2M on 2025-06-13), while the full window spans 2021-02-15 (Sanctify Financial Technologies, Angel, $900K) through 2025-11-18. Sector-wise, Biotechnology appears most frequently (11 entries), followed by Health Care (4 entries) and AI (3 entries).
Most recent rounds
39 shownRelated listings
Frequently asked
What stands out as the largest disclosed round in Lund, and how extreme is it vs the rest?
AlixLabs’ $16M Series A on 2025-11-18 is the top disclosed amount in these 39 rows, with the next-largest disclosed amounts at $13M (Enzymatica, 2024-09-12) and $8M (Zerotude, 2024-11-04). The gap suggests one company sits in a higher disclosed-dollar tier than the rest of the list.
Are there meaningful clusters in time among the most recent Lund rounds?
Yes. In mid-2025 alone, several disclosed deals land close together: TerraNet $2M on 2025-06-13, Cantargia $3M on 2025-06-17, Qlucore $580K on 2025-06-24, and SynAct Pharma $2M on 2025-07-15. The most recent entry is AlixLabs on 2025-11-18, while the oldest shown is Sanctify Financial Technologies on 2021-02-15.
How should sales or research teams interpret stage reporting quality on this page?
Stage labeling is inconsistent: 20 of 39 rows are “Series Unknown,” which limits stage-based prioritization. Additionally, 3 rows show “undisclosed” amounts (Cocoon Airbag Protection on 2024-09-19; EpinovaTech on 2024-05-14; DealGuru on 2024-01-11; Qoitech and SenseNode also appear as “undisclosed” by amount).
Which sectors are over-represented in these Lund-funded entries?
Biotechnology is the dominant vertical with 11 entries (e.g., SynAct Pharma $2M on 2025-07-15; Cantargia $3M on 2025-06-17; BioInvent $3M on 2023-04-26; Hamlet Pharma $330K on 2023-04-14). Health Care follows with 4 entries (e.g., Enzymatica $13M on 2024-09-12; PharmNovo $7M on 2022-07-03).
Are there outliers besides the top disclosed round, especially near the low end?
The smallest disclosed amount is $40K for Parlametric (Data and Analytics) on 2023-05-17, which is far below most other disclosed rounds (many are in the $300K–$4M band, such as BeammWave $330K on 2023-06-22 and BioInvent $3M on 2023-04-26). On the other end, large disclosed concentrations also appear at Enzymatica $13M (2024-09-12) and Zerotude $8M (2024-11-04), marking a small upper cluster.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.